Clinical Research Directory
Browse clinical research sites, groups, and studies.
Standalone iStent Infinite and iDose TR for Management of Moderate to Severe Open Angle Glaucoma
Sponsor: Jonathon Myers
Summary
The Investigators will investigate the efficacy of combining the standalone iStent infinite and iDose that are minimally invasive surgical and drug depot options are a safe and effective alternative to filtering surgery for intraocuar pressure reduction in patients with medically uncontrolled open angle glaucoma.
Official title: iStent Infinite and iDose TR for Management of Moderate to Severe Primary Open Angle Glaucoma Are a Safe and Effective Alternative to Filtering Surgery for IOP Reduction in Patients With Medically Uncontrolled Glaucoma. (POAG)
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
20
Start Date
2026-01-05
Completion Date
2031-12-31
Last Updated
2025-11-14
Healthy Volunteers
No
Interventions
iStent infinite trabecular micro-bypass system model iS3
surgery perfomed using the iStent infinite trabecular micro-bypass system model iS3
iDose TR (Travoprost intracameral Implant) 75mcg
surgery performed using the iDose TR (Travoprost intracameral Implant) 75mcg
Locations (1)
Wills Eye Hosital Glaucoma Dept.
Philadelphia, Pennsylvania, United States